|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0021753,
umls-concept:C0021760,
umls-concept:C0032105,
umls-concept:C0032854,
umls-concept:C0035222,
umls-concept:C0040223,
umls-concept:C0079189,
umls-concept:C0205322,
umls-concept:C0332290,
umls-concept:C0333348,
umls-concept:C0441889,
umls-concept:C0681842,
umls-concept:C0702240,
umls-concept:C1274040,
umls-concept:C1561558,
umls-concept:C2698872
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1995-5-11
|
|
pubmed:abstractText |
Inflammatory cytokines have been related to the development of adult respiratory distress syndrome (ARDS), shock, and multiple organ dysfunction syndrome (MODS). We tested the hypothesis that unfavorable outcome in patients with ARDS is related to the presence of a persistent inflammatory response. For this purpose, we evaluated the behavior of inflammatory cytokines during progression of ARDS and the relationship of plasma inflammatory cytokines with clinical variables and outcome.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0012-3692
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
107
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1062-73
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:7705118-Adult,
pubmed-meshheading:7705118-Female,
pubmed-meshheading:7705118-Humans,
pubmed-meshheading:7705118-Interleukin-1,
pubmed-meshheading:7705118-Interleukin-2,
pubmed-meshheading:7705118-Interleukin-4,
pubmed-meshheading:7705118-Interleukin-6,
pubmed-meshheading:7705118-Interleukin-8,
pubmed-meshheading:7705118-Interleukins,
pubmed-meshheading:7705118-Male,
pubmed-meshheading:7705118-Middle Aged,
pubmed-meshheading:7705118-Prognosis,
pubmed-meshheading:7705118-Prospective Studies,
pubmed-meshheading:7705118-Respiratory Distress Syndrome, Adult,
pubmed-meshheading:7705118-Sensitivity and Specificity,
pubmed-meshheading:7705118-Survival Rate,
pubmed-meshheading:7705118-Time Factors,
pubmed-meshheading:7705118-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time.
|
|
pubmed:affiliation |
Pulmonary and Critical Care Division, University of Tennessee Medical Center, Memphis, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|
